首頁 > 市場調查報告書 > 製藥

再生醫學

市場調查報告書

商品編碼

1961060

全球幹細胞庫市場：市場規模、產業動態、機會分析及預測（2026-2035 年），依分析服務類型、用途、細胞類型及地區劃分

Global Stem Cell Banking Market: By Analysis Service Type, Utilization, Cell Type, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035

出版日期: 2026年01月19日 | 出版商:

Astute Analytica | 英文 310 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

全球幹細胞庫市場正經歷快速擴張，反映出人們對再生醫學日益增長的興趣和取得的進展。 2025 年，該市場規模約為 77.5 億美元，預計未來十年將顯著成長，到 2035 年將達到 279.5 億美元。這一顯著增長意味著 2026 年至 2035 年預測期內的複合年增長率 (CAGR) 為 15.32%，表明該領域需求強勁，投資旺盛。

推動這令人矚目的成長軌跡的關鍵因素有很多。其中一個關鍵驅動因素是專注於再生醫學的臨床試驗數量不斷增加，這正在擴大幹細胞的治療潛力。這些試驗探討了針對多種疾病（從遺傳性疾病到慢性病）的創新療法，凸顯了幹細胞在下一代療法中的關鍵作用。再生醫學的進步不僅激發了科學界的興趣，也增強了患者和醫療保健提供者對幹細胞療法療效的信心。

市場趨勢

幹細胞庫市場正在整合，前五大公司佔了全球超過 54% 的市場。這種集中度反映了主要參與者利用其規模、技術和地理覆蓋範圍來實現區域主導地位和國際擴張的戰略驅動力。 CBR Systems（也稱為 California Cryobank）以超過 110 萬份新生兒幹細胞樣本引領市場。

Revvity 的子公司 ViaCord 憑藉其尖端處理技術脫穎而出，顯著提高了細胞回收率。這項技術優勢使該公司能夠提供高品質的幹細胞產品，從而滿足客戶對儲存樣本最佳效果的需求。同時，LifeCell International以其創新的 "社區銀行" 模式進軍印度市場，引領了新的潮流。

在東南亞，Cordlife Group已在新加坡、香港和菲律賓等主要市場建立了強大的影響力。憑藉在地化的專業知識和客製化的服務，該公司在這個快速成長的市場中佔了相當大的佔有率。這些領導企業正透過內生式成長以及併購來加速發展。

核心成長驅動因子

幹細胞庫需求的激增並非孤立現象。相反，它是多種人口結構變化和重要流行病學趨勢共同作用的結果，這些變化正在從根本上改變世界醫療保健的方式。推動這一增長的最重要因素之一是全球慢性病和遺傳性疾病負擔的惡化。隨著人口老化和生活方式的改變，癌症和自體免疫疾病等疾病的盛行率越來越高，迫切需要新的疾病預防、管理和治療策略。

新機會與趨勢

2025年，幹細胞庫市場將迎來重大變革。其關注點將從簡單的生物材料保存轉向採用先進的生物資訊技術。這項演化標誌著幹細胞冷凍保存模式正從傳統的模式轉向更全面、更先進的方法，整合尖端基因組技術。目前，各大幹細胞庫正透過將保存服務與完整的基因組分析相結合來擴展其服務範圍，從而實現對新生兒DNA的詳細分析。這個過程有助於在生命早期識別和繪製潛在的健康風險圖譜，提供超越幹細胞保存本身的寶貴見解。

優化障礙

由於嚴格、分散且頻繁變化的國際法規，幹細胞庫市場面臨巨大的挑戰。這種監管複雜性在美國和歐盟等主要市場尤為突出，因為每個主管機構都制定了嚴格的標準，以確保幹細胞材料的安全性、品質和倫理處理。應對這些繁雜且嚴格的監管規定給幹細胞庫運營商帶來了沉重的負擔，需要投入大量成本，包括法律專業知識、營運協調和持續監管等方面的投入。這種監管負擔會扼殺創新，使跨國營運複雜化，導致企業難以簡化流程並有效擴大全球業務規模。

產業價值鏈分析
- 服務提供者
- 最終用戶
行業展望
- 主要國家癌症統計（2025 年）
- 各國當前人均醫療支出（美元）
PESTLE 分析
波特五力分析
- 供應商議價能力
- 買方議價能力
- 替代品威脅
- 新進入者威脅
- 競爭強度
市場動態與趨勢
- 成長驅動因素
- 限制因素
- 挑戰
- 主要趨勢
市場成長與展望
- 市場收入估算與預測（2020-2035 年）
- 價格趨勢分析
競爭格局概覽
- 市場集中度
- 公司佔有率分析（基於價值，2025 年）
- 競爭格局分析與基準分析

第五章：全球幹細胞庫市場依服務類型分析

主要發現
市場規模與預測（2020-2035 年）
- 採集與運輸
- 處理
- 分析
- 存儲

第六章：全球幹細胞庫市場依用途分析

關鍵研究結果
市場規模及預測，2020-2035 年
- 已使用
- 未使用

第七章全球幹細胞庫市場分析：依幹細胞類型劃分

主要見解
市場規模及預測，2020-2035 年
- 臍帶血幹細胞
- 成體幹細胞
- 胚胎幹細胞

第八章全球幹細胞庫市場分析：依地區劃分

主要見解
市場規模及預測，2020-2035 年
- 北美
- 歐洲
- 亞太地區
- 中東和非洲
- 南美洲

第九章：北美幹細胞庫市場分析

第十章：歐洲幹細胞庫市場分析

第十一章：亞太地區幹細胞庫市場分析

第十二章：中東與非洲幹細胞庫市場分析

第十三章：南美洲幹細胞庫市場分析

第14章企業簡介

Biocell
CBR Systems, Inc.
Cordlife
Cryo-Cell International, Inc.
CryoSave South Africa(Pty)Ltd.
Cryoviva
Future Health Biobank
LifeCell International Pvt. Ltd.
Smart Cells International Ltd
ViaCord
Other Prominent Players

簡介目錄

Product Code: AA01261656

The global stem cell banking market is undergoing rapid expansion, reflecting growing interest and advancements in regenerative medicine. Valued at approximately USD 7.75 billion in 2025, the market is projected to experience substantial growth over the next decade, with forecasts estimating it will reach a valuation of USD 27.95 billion by 2035. This remarkable increase corresponds to a compound annual growth rate (CAGR) of 15.32% during the forecast period from 2026 to 2035, signaling robust demand and investment across the sector.

Several key factors are driving this impressive growth trajectory. One of the primary catalysts is the rising number of clinical trials focused on regenerative medicine, which is expanding the therapeutic potential of stem cells. These trials are exploring innovative treatments for a wide range of diseases, from genetic disorders to chronic conditions, highlighting the critical role stem cells play in next-generation therapies. The progress in regenerative medicine not only fuels scientific interest but also increases patient and healthcare provider confidence in the efficacy of stem cell-based treatments.

Noteworthy Market Developments

The stem cell banking market is increasingly defined by consolidation, with the top five players capturing over 54% of the global market share. This concentration reflects a strategic push by leading companies to leverage scale, technology, and geographic reach to dominate their respective regions and expand internationally. CBR Systems, also known as California Cryobank, leads the market in volume, boasting an inventory of more than 1.1 million newborn stem cell samples.

ViaCord, now part of Revvity, distinguishes itself through cutting-edge processing technologies that significantly enhance cell recovery rates. This technological edge allows ViaCord to offer superior quality stem cell products, which appeals to clients seeking the best possible outcomes from their stored samples. Meanwhile, LifeCell International has disrupted the Indian market with an innovative "community banking" model.

In Southeast Asia, Cordlife Group has established a stronghold, thriving in key markets such as Singapore, Hong Kong, and the Philippines. Their regional expertise and tailored service offerings have helped them capture a significant share of this growing market. These leading companies are not only expanding organically but are also accelerating growth through mergers and acquisitions.

Core Growth Drivers

The surge in demand for the stem cell banking market is not a phenomenon occurring in isolation; rather, it is the result of several converging demographic shifts and significant epidemiological trends that are fundamentally transforming the approach to healthcare worldwide. One of the most influential drivers behind this growing interest is the increasing global burden of chronic and genetic diseases. As populations age and lifestyles change, conditions such as cancer and autoimmune disorders are becoming more prevalent, creating an urgent need for new strategies in disease prevention, management, and treatment.

Emerging Opportunity Trends

In 2025, the stem cell banking market undergoes a significant transformation as the focus shifts from simply storing biological materials to embracing advanced bioinformatics. This evolution marks a departure from the traditional model of freezing and preserving stem cells toward a more comprehensive and sophisticated approach that integrates cutting-edge genomic technologies. Leading stem cell banks are now expanding their service offerings by combining storage with full genomic profiling, allowing them to sequence the newborn's DNA in detail. This process enables the identification and mapping of potential health risks early in life, providing valuable insights that go far beyond the preservation of stem cells alone.

Barriers to Optimization

The stem cell banking market faces significant challenges due to stringent, fragmented, and frequently evolving international regulations. These regulatory complexities are especially pronounced in major markets such as the United States and the European Union, where governing bodies impose rigorous standards to ensure the safety, quality, and ethical handling of stem cell materials. Compliance with these diverse and often stringent regulations demands substantial investments in legal expertise, operational adjustments, and ongoing monitoring, all of which contribute to increased costs for stem cell banking providers. This regulatory burden can slow down innovation and complicate cross-border operations, making it more difficult for companies to streamline processes and scale efficiently on a global level.

Detailed Market Segmentation

By Utilization, the unused segment, which consists of stem cell units that have been cryopreserved but not yet released or utilized, dominates the volume of the stem cell banking market. This prevalence is largely a reflection of the significant gap between the rates at which stem cells are preserved and the rates at which they are actually used. While many individuals and families choose to bank stem cells as a precautionary measure or biological safeguard, the actual clinical application of these stored units remains relatively low in comparison. This economic reality shapes the market's volume dynamics, with a large inventory of preserved cells remaining in storage without immediate demand for release or treatment.

By Service Type, the storage segment holds the largest value share in the stem cell banking market because it serves as the industry's primary source of recurring revenue. Unlike one-time services such as collection or processing, storage involves ongoing fees that clients pay regularly to maintain the preservation of their stem cell samples over extended periods. This continuous revenue stream provides financial stability and growth potential for stem cell banks, making storage a critical component of their business models.

By Bank, the private bank segment overwhelmingly dominates the global stem cell banking market, commanding approximately 97% of the industry's financial value. This significant market share highlights the strong preference among consumers and healthcare providers for private banking services over other types of stem cell storage options. Private banks offer exclusive storage of an individual's stem cells, typically for personal or family use, which appeals to many who view this as a form of biological insurance for potential future medical treatments. This personalized approach not only drives higher revenue per client but also fosters a deep sense of security and control, factors that contribute to the segment's financial dominance.

By Cell Type, the umbilical cord stem cell segment holds the largest share within the stem cell banking market, a position it has secured due to several compelling advantages. One of the primary reasons for its dominance is the superior biological plasticity of umbilical cord stem cells. These cells possess a remarkable ability to differentiate into a wide range of cell types, making them highly valuable for various regenerative medicine applications and potential therapeutic interventions. Their versatility enhances their appeal to both medical professionals and prospective clients, as they offer promising prospects for treating a broad spectrum of diseases and conditions.

Segment Breakdown

By Service Type

Collection & Transportation
Processing
Analysis
Storage

By Utilization

Used
Unused

By Cell Type

Umbilical Cord Stem Cell
Adult Stem Cell
Embryonic Stem Cell

By Region

North America
Europe
Asia Pacific
Middle East and Africa
South America

Geography Breakdown

North America continues to dominate the industry, accounting for approximately 38% to 40% of the market revenue in 2026. This stronghold is underpinned by a combination of deep-rooted structural advantages that set the region apart from others. At the core of this dominance is North America's status as the home to the world's most advanced regenerative medicine infrastructure.
In addition to the sophisticated medical infrastructure, North America benefits from high disposable incomes that enable many families to invest in premium health services, including stem cell banking. The cultural acceptance and enthusiasm for "paying for health edges" further fuel this adoption, as consumers are increasingly willing to pay upfront for services that they perceive as long-term investments in their children's health and future well-being.

Leading Market Participants

Biocell
CBR Systems, Inc.
Cordlife
Cryo-Cell International, Inc.
CryoSave South Africa (Pty) Ltd.
Cryoviva
Future Health Biobank
LifeCell International Pvt. Ltd.
Smart Cells International Ltd
ViaCord
Other Prominent Players

Table of Content

Chapter 1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

Chapter 2. Research Methodology

2.1. Qualitative Research
- 2.1.1. Primary & Secondary Sources
2.2. Quantitative Research
- 2.2.1. Primary & Secondary Sources
2.3. Breakdown of Primary Research Respondents, By Country
2.4. Assumption for the Study
2.5. Market Size Estimation
2.6. Data Triangulation

Chapter 3. Executive Summary: Global

Chapter 4. Global Stem Cell Banking Market Overview

4.1. Industry Value Chain Analysis
- 4.1.1. Service Provider
- 4.1.2. End User
4.2. Industry Outlook
- 4.2.1. Cancer Statistics in Major Countries, 2025
- 4.2.2. Current health expenditure per capita (current US$) - By Country
4.3. PESTLE Analysis
4.4. Porter's Five Forces Analysis
- 4.4.1. Bargaining Power of Suppliers
- 4.4.2. Bargaining Power of Buyers
- 4.4.3. Threat of Substitutes
- 4.4.4. Threat of New Entrants
- 4.4.5. Degree of Competition
4.5. Market Dynamics and Trends
- 4.5.1. Growth Drivers
- 4.5.2. Restraints
- 4.5.3. Challenges
- 4.5.4. Key Trends
4.6. Market Growth and Outlook
- 4.6.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
- 4.6.2. Price Trend Analysis
4.7. Competition Dashboard
- 4.7.1. Market Concentration Rate
- 4.7.2. Company Market Share Analysis (Value %), 2025
- 4.7.3. Competitor Mapping & Benchmarking

Chapter 5. Global Stem Cell Banking Market Analysis, By Service Type

5.1. Key Insights
5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 5.2.1. Collection & Transportation
- 5.2.2. Processing
- 5.2.3. Analysis
- 5.2.4. Storage

Chapter 6. Global Stem Cell Banking Market Analysis, By Utilization

6.1. Key Insights
6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 6.2.1. Used
- 6.2.2. Unused

Chapter 7. Global Stem Cell Banking Market Analysis, By Stem Cell Type

7.1. Key Insights
7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 7.2.1. Umbilical Cord Stem Cell
- 7.2.2. Adult Stem Cell
- 7.2.3. Embryonic Stem Cell

Chapter 8. Global Stem Cell Banking Market Analysis, By Region

8.1. Key Insights
8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 8.2.1. North America
  - 8.2.1.1. The U.S.
  - 8.2.1.2. Canada
  - 8.2.1.3. Mexico
- 8.2.2. Europe
  - 8.2.2.1. Western Europe
    - 8.2.2.1.1. The UK
    - 8.2.2.1.2. Germany
    - 8.2.2.1.3. France
    - 8.2.2.1.4. Italy
    - 8.2.2.1.5. Spain
    - 8.2.2.1.6. Rest of Western Europe
  - 8.2.2.2. Eastern Europe
    - 8.2.2.2.1. Poland
    - 8.2.2.2.2. Russia
    - 8.2.2.2.3. Rest of Eastern Europe
- 8.2.3. Asia Pacific
  - 8.2.3.1. China
  - 8.2.3.2. India
  - 8.2.3.3. Japan
  - 8.2.3.4. South Korea
  - 8.2.3.5. Australia & New Zealand
  - 8.2.3.6. ASEAN
  - 8.2.3.7. Rest of Asia Pacific
- 8.2.4. Middle East & Africa
  - 8.2.4.1. UAE
  - 8.2.4.2. Saudi Arabia
  - 8.2.4.3. South Africa
  - 8.2.4.4. Rest of MEA
- 8.2.5. South America
  - 8.2.5.1. Argentina
  - 8.2.5.2. Brazil
  - 8.2.5.3. Rest of South America

Chapter 9. North America Stem Cell Banking Market Analysis

9.1. Market Dynamics and Trends
- 9.1.1. Growth Drivers
- 9.1.2. Restraints
- 9.1.3. Opportunity
- 9.1.4. Key Trends
9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 9.2.1. By Service Type
- 9.2.2. By Utilization
- 9.2.3. By Stem Cell Type
- 9.2.4. By Country

Chapter 10. Europe Stem Cell Banking Market Analysis

10.1. Market Dynamics and Trends
- 10.1.1. Growth Drivers
- 10.1.2. Restraints
- 10.1.3. Opportunity
- 10.1.4. Key Trends
10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 10.2.1. By Service Type
- 10.2.2. By Utilization
- 10.2.3. By Stem Cell Type
- 10.2.4. By Country

Chapter 11. Asia Pacific Stem Cell Banking Market Analysis

11.1. Market Dynamics and Trends
- 11.1.1. Growth Drivers
- 11.1.2. Restraints
- 11.1.3. Opportunity
- 11.1.4. Key Trends
11.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 11.2.1. By Service Type
- 11.2.2. By Installation Type
- 11.2.3. By Stem Cell Type
- 11.2.4. By Country

Chapter 12. Middle East & Africa Stem Cell Banking Market Analysis

12.1. Market Dynamics and Trends
- 12.1.1. Growth Drivers
- 12.1.2. Restraints
- 12.1.3. Opportunity
- 12.1.4. Key Trends
12.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 12.2.1. By Service Type
- 12.2.2. By Installation Type
- 12.2.3. By Utilization
- 12.2.4. By Stem Cell Type
- 12.2.5. By Country

Chapter 13. South America Stem Cell Banking Market Analysis

13.1. Market Dynamics and Trends
- 13.1.1. Growth Drivers
- 13.1.2. Restraints
- 13.1.3. Opportunity
- 13.1.4. Key Trends
13.2. Market Size and Forecast, 2020-2035 (US$ Mn)
- 13.2.1. By Service Type
- 13.2.2. By Utilization
- 13.2.3. By Stem Cell Type
- 13.2.4. By Country